AbbVie and Pfizer receive approvals for new cancer and hemophilia treatments
ABBV
Statements (2)
- Bullish
AbbVie received FDA approval for a once-daily Parkinson's pill
- Bullish
AbbVie received FDA approval for a once-daily Parkinson's medication
AbbVie received FDA approval for a once-daily Parkinson's pill
AbbVie received FDA approval for a once-daily Parkinson's medication